NCT03367247 2026-03-10
BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal
Dana-Farber Cancer Institute
Phase NA Completed
Clinical Trials
12 trialsNCT02799212 2025-10-03
SOMAPROTECT01
Hospices Civils de Lyon
Phase 3 Completed
NCT04540159 2022-12-06
Immune Checkpoints in Intraabdominal Ascites Fluid
Istanbul Training and Research Hospital
Completed
NCT04540146 2021-07-27
T Helper Cytokines in End Stage Colorectal Cancers
Istanbul Training and Research Hospital
Completed
NCT01532427 2020-10-26
2011-AAR-004
Sequana Medical N.V.
Completed
NCT00825877 2019-12-17
Long-term Follow-up of HALT-C Sustained Virological Responders
National Institutes of Health Clinical Center (CC)
Completed
NCT00552955 2019-03-06
Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women
National Institutes of Health Clinical Center (CC)
Completed
NCT00326885 2018-10-17
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Neovii Biotech
Phase 2 Completed
NCT02638051 2017-05-19
OTMA-RII
Galenic Research Institute Ltd
Phase 2 Completed
NCT00327444 2013-01-01
Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites
Sanofi
Phase 2/3 Completed
NCT01150916 2012-12-20
B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites
University of Sao Paulo
Phase NA Completed
NCT00005906 2010-04-30
Treatment With Octreotide in Patients With Lymphangioleiomyomatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed